CIK: 1123343 - Address: C/O Travere Therapeutics, Inc., 3611 Valley Centre Dr., Suite 300, San Diego, CA 92130
11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
10/4/24 19:15
10/4/24
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsLyons Gary ACADS.d-58914.730-40-4451D
8/15/24 17:21
8/13/24
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagLyons Gary ACADS.d-1,740150.430-12-9119D
7/18/24 16:54
7/16/24
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagLyons Gary ACADS.d-140150.030-1-1119D
5/16/24 16:55
5/14/24
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagLyons Gary ACADS.d-1,695135.630-13-10117D
12/27/23 16:10
12/22/23
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagLyons Gary ACADS-1,300130.040-10-5194D
12/5/23 16:54
12/1/23
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagLyons Gary ACADS.d-584116.770-5-2204D
9/14/23 16:51
9/12/23
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagLyons Gary ACADS.d-575115.020-5-2204D
9/6/23 16:25
9/1/23
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagLyons Gary ACADS.d-550110.060-5-2204D
11/2/22 18:42
10/31/22
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagLyons Gary ACADS.d-1,721114.760-15-7204D
10/5/22 19:00
10/4/22
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagLyons Gary ACADS-553110.540-5-2204D
4/27/22 17:26
4/25/22
NBIXNeurocrine Biosciences IncDEHealthBioPrdBiological Products, (No DiagLyons Gary ACADS.d-1,39192.760-15-7209D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact